Earnings Call · Q2 FY2025·2025-08-06

Q2 25EPS +29.17%·Rev n/aQ1 25EPS +35.48%·Rev n/aQ4 24EPS +4.17%·Rev n/aQ3 24EPS +18.52%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad M. Robins — Chief Executive Officer

Kyle Piskel — Chief Financial Officer

+1.3%1d on move date+1.8% vs SPY3d+14.9%5d+11.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access